GlaxoSmithKline Plc (GSK) is adding new products in China and hiring “a few hundred” more salespeople to promote them, betting that health-care reforms will widen access to drugs and make up for state-mandated price cuts.
The drugmaker will expand its sales force of 4,000 in China this year after hiring more than 700 people in 2011, Chief Executive Officer Andrew Witty said today in Beijing.
via bloomberg.com
No comments:
Post a Comment